Novartis AG (NVS) Q1 2026 Earnings Call Transcript
Novartis AG reported its first-quarter 2026 earnings, missing on EPS but beating on revenue. The company recorded a year-over-year decline in revenue, though the drop was smaller than expected. Executives discussed performance drivers and strategic priorities during the earnings call.
- ▪Novartis AG reported an EPS of $1.99, missing estimates by $0.08.
- ▪The company's Q1 2026 revenue was $13.52 billion, a 0.70% decrease year-over-year.
- ▪Despite the revenue decline, Novartis beat revenue expectations by $43.88 million.
- ▪CEO Vasant Narasimhan and CFO Mukul Mehta participated in the earnings call.
- ▪The call included discussions on operational performance and future strategy.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4895066-novartis-ag-nvs-q1-2026-earnings-call-transcript"},"author":{"@type":"Person","name":"SA Transcripts","url":"https://seekingalpha.com/author/sa-transcripts"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New York","addressRegion":"NY","postalCode":"10001","addressCountry":"US"},"alternateName":["SeekingAlpha","SA"],"brand":[{"@type":"Brand","name":"Seeking Alpha Premium","url":"https://seekingalpha.com/subscriptions/premium"},{"@type":"Brand","name":"Seeking Alpha PRO","url":"https://seekingalpha.com/subscriptions"},{"@type":"Brand","name":"Alpha…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
